Received Sep 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) for COVID-19 prophylaxis. The patient's past medical history included CAPD (CAPD (dialysis)) since an unknown date. Concurrent medical conditions included Type 1 diabetes mellitus. On 19-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (unknown route) 1 dosage form. In October 2023, after starting mRNA-1273.815 (SPIKEVAX 2023-2024 PFS), the patient experienced VOMITING (Vomiting). In October 2023, VOMITING (Vomiting) had resolved. No concomitant medications were provided. It was reported that patient had taken all Covid vaccines since 2021 till now, which was 7-8 vaccines. It was reported that at each time almost 10 hours after the vaccine she would start vomiting every 20 to 30 minutes and this would last for 6-8 hours. It was reported that she had always taken Moderna vaccines. The patient received the Moderna COVID-19 vaccine in 2021. On 28-Apr-2022, patient received a 0.5 mL dose of the Moderna COVID-19 Vaccine Booster. On 15-Jan-2023, the patient was administered the Moderna COVID-19 Bivalent Vaccine. Patient had received other 4 vaccines (Spikevax NOS), but she had no information about them. It was mentioned that she had diabetes type 1 and was on dialysis (CAPD). No treatment medication was provided. This case was linked to MOD-2025-789725 (Patient Link).
CAPD (CAPD (dialysis)); Type 1 diabetes mellitus